CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Ultragenyx prices Sanfilippo gene therapy at $4M; Bristol Myers shelves Orum drug

Sanfilippo gene therapyOrumNeutral
AI Analysis

Summary

Ultragenyx announced pricing for its Sanfilippo gene therapy at $4 million, while Bristol Myers Squibb discontinued development of its Orum drug program.

Importance:3/10
Sentiment:
0.00
pricinggene therapydrug developmentprogram discontinuation
Related Companies

Read the original article

Published by yahoo_finance on September 18, 2026 10:24 AM

Read Original